Literature DB >> 19000747

Effect of amyloid beta on capacitive calcium entry in neural 2a cells.

Ying Niu1, Zuqi Su, Chang Zhao, Bo Song, Xiufang Zhang, Nanming Zhao, Xun Shen, Yandao Gong.   

Abstract

We studied the direct role of amyloid beta (Abeta) in regulating capacitive calcium entry (CCE), an important refilling mechanism for depleted intracellular calcium stores. For the first time, we found that Abeta can potentiate CCE. Neural 2a cells stably expressing Swedish mutant APP (APPswe), which can secrete large amounts of Abeta, have stronger CCE than its wild-type controls. Either reducing the Abeta in the medium by antibody binding or decreasing Abeta production by gamma secretase inhibitor treatment could significantly depress CCE in APPswe cells. The results demonstrated that the CCE potentiation in APPswe cells was caused by Abeta over-expression. Our research also revealed that the effect of Abeta on CCE potentiation could be decreased by Abeta channel blocker, which showed that the channels formed by Abeta are one of the ways through which Abeta causes CCE potentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000747     DOI: 10.1016/j.brainresbull.2008.10.003

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

Review 1.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

2.  Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.

Authors:  Bénédicte Oulès; Dolores Del Prete; Barbara Greco; Xuexin Zhang; Inger Lauritzen; Jean Sevalle; Sebastien Moreno; Patrizia Paterlini-Bréchot; Mohamed Trebak; Frédéric Checler; Fabio Benfenati; Mounia Chami
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

3.  APP Genetic Deficiency Alters Intracellular Ca2+ Homeostasis and Delays Axonal Degeneration in Dorsal Root Ganglion Sensory Neurons.

Authors:  Andrés de León; Julien Gibon; Philip A Barker
Journal:  J Neurosci       Date:  2022-07-25       Impact factor: 6.709

4.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

Review 5.  New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc.

Authors:  C Corona; A Pensalfini; V Frazzini; S L Sensi
Journal:  Cell Death Dis       Date:  2011-06-23       Impact factor: 8.469

Review 6.  Ryanodine receptors: physiological function and deregulation in Alzheimer disease.

Authors:  Dolores Del Prete; Frédéric Checler; Mounia Chami
Journal:  Mol Neurodegener       Date:  2014-06-05       Impact factor: 14.195

Review 7.  Alterations of the Endoplasmic Reticulum (ER) Calcium Signaling Molecular Components in Alzheimer's Disease.

Authors:  Mounia Chami; Frédéric Checler
Journal:  Cells       Date:  2020-12-01       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.